Pancreatic Diseases clinical trials at UC Cancer
1 research study open to eligible people
A Study of Experimental Cefoxitin or Piperacillin-Tazobactam to Prevent Postoperative Infections After Pancreatic Cancer Surgery
“This study hopes to determine whether Cefoxitin or Piperacillin-Tazobactam prevents postoperative infections better.”
open to eligible people ages 18 years and up
The purpose of this study is to figure out which commonly used antibiotic, cefoxitin or piperacillin-tazobactam, is better at decreasing the rate of surgical site infections after pancreatoduodenectomy.
at UC Davis